Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report for financial year 2022-23
28-07-2023
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Reg. 34 (1) Annual Report.

Annual Report for financial year 2022-23
28-07-2023
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Notice Of Annual General Meeting

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
28-07-2023
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Submission of Information of loss of share certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
22-07-2023
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
13-07-2023
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
30-06-2023
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Closure of Trading Window

Intimation of Trading Window Closure period.
29-06-2023
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Issue of letter of confirmation for duplicate share certificates - Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
23-06-2023

JB Chemicals hits record high as Jefferies initiates coverage with 'buy' call

Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies
20-06-2023
Next Page
Close

Let's Open Free Demat Account